Apyx Medical Corporation (APYX)
NASDAQ: APYX
· Real-Time Price · USD
2.15
0.03 (1.42%)
At close: Aug 15, 2025, 2:08 PM
Apyx Medical Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 46.51M | 47.29M | 48.1M | 48.54M | 49.03M | 50.45M | 52.35M | 50.3M | 47.44M | 44.16M | 44.51M | 48.72M | 51.44M | 52.37M | 48.52M | 43.16M | 38.28M | 31.35M |
Cost of Revenue | 17.85M | 22.89M | 27.72M | 33.06M | 36.52M | 31.48M | 27.45M | 21.23M | 16.59M | 15.67M | 15.38M | 15.68M | 16.1M | 16.41M | 14.92M | 14.01M | 12.46M | 10.97M |
Gross Profit | 28.67M | 24.39M | 29.36M | 24.46M | 20.82M | 27.28M | 24.23M | 28.4M | 30.85M | 28.48M | 29.13M | 33.04M | 35.34M | 35.96M | 33.6M | 29.15M | 25.82M | 20.38M |
Operating Income | -12.31M | -15.28M | -18.84M | -21.57M | -22.57M | -18.26M | -17.26M | -17.42M | -18.56M | -23.3M | -23.56M | -19.32M | -17.51M | -15.57M | -14.45M | -14.81M | -15.21M | -17.34M |
Interest Income | 1.25M | 1.42M | 1.61M | 1.75M | 1.63M | 1.36M | 921K | 542K | 367K | 206K | 157K | 95K | 24K | 10K | 11K | 17K | 25K | 28K |
Pretax Income | -17.05M | -19.89M | -23.31M | -28.27M | -28.6M | -23.02M | -21.28M | -17.66M | -18.41M | -22.81M | -22.91M | -18.87M | -17.29M | -15.88M | -14.82M | -14.87M | -15.15M | -17.39M |
Net Income | -17.26M | -20.04M | -23.46M | -28.44M | -28.37M | -22.81M | -18.76M | -15.2M | -16.37M | -20.83M | -23.26M | -19.22M | -17.64M | -16.24M | -15.17M | -14.7M | -14.2M | -14.85M |
Selling & General & Admin | 27.86M | 30.66M | 32.17M | 29.87M | 25.26M | 30.34M | 37.5M | 41.83M | 47.47M | 47.28M | 48.15M | 48.13M | 48.5M | 47.17M | 43.73M | 39.67M | 36.87M | 33.66M |
Research & Development | 3.89M | 4.49M | 5.08M | 5.21M | 5.34M | 5.12M | 4.84M | 4.85M | 4.64M | 4.51M | 4.54M | 4.24M | 4.35M | 4.36M | 4.32M | 4.29M | 4.16M | 4.05M |
Other Expenses | 4.93M | 4.53M | 10.95M | 10.95M | 12.78M | 12.78M | 1.83M | 1.83M | -40K | -40K | -56K | -56K | -21K | 76K | 4K | 4K | -59K | -170K |
Operating Expenses | 36.68M | 39.67M | 48.2M | 46.03M | 43.39M | 48.24M | 44.18M | 48.51M | 52.1M | 51.79M | 52.69M | 52.36M | 52.85M | 51.53M | 48.05M | 43.96M | 41.03M | 37.72M |
Interest Expense | 3.1M | 3.13M | 5.91M | 5.37M | 4.52M | 3.64M | 2.48M | 1.36M | 781K | 241K | 15K | 13K | 15K | 14K | 10K | 16K | 38K | 44K |
Selling & Marketing Expenses | n/a | -4.68M | -10.95M | -15.82M | -22.32M | -17.64M | -11.37M | -6.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 58.82M | 62.57M | 66.95M | 70.11M | 71.61M | 71.41M | 72.3M | 70.41M | 68.69M | 67.46M | 68.07M | 68.04M | 68.95M | 67.95M | 62.97M | 57.97M | 53.49M | 48.69M |
Income Tax Expense | 247K | 248K | 252K | 250K | -128K | -112K | -2.43M | -2.37M | -2M | -1.97M | 367K | 350K | 373K | 384K | 380K | -145K | -933K | -2.53M |
Shares Outstanding (Basic) | 40.73M | 35.54M | 38.22M | 34.64M | 34.64M | 34.64M | 34.64M | 34.64M | 34.6M | 34.6M | 34.6M | 34.57M | 34.46M | 34.43M | 34.37M | 34.33M | 33.72M | 34.3M |
Shares Outstanding (Diluted) | 40.73M | 35.54M | 38.22M | 34.64M | 34.64M | 34.64M | 34.64M | 34.64M | 34.6M | 34.6M | 34.6M | 34.57M | 34.46M | 34.43M | 34.37M | 34.33M | 34.32M | 34.3M |
EPS (Basic) | -0.47 | -0.57 | -0.67 | -0.83 | -0.82 | -0.66 | -0.54 | -0.43 | -0.47 | -0.6 | -0.67 | -0.56 | -0.51 | -0.47 | -0.44 | -0.42 | -0.41 | -0.43 |
EPS (Diluted) | -0.47 | -0.57 | -0.67 | -0.83 | -0.82 | -0.66 | -0.54 | -0.43 | -0.47 | -0.6 | -0.67 | -0.56 | -0.51 | -0.47 | -0.44 | -0.42 | -0.41 | -0.43 |
EBITDA | -11.49M | -13.87M | -16.8M | -22.3M | -23.43M | -18.73M | -18.11M | -15.55M | -16.86M | -21.7M | -22.01M | -17.94M | -16.34M | -14.96M | -13.91M | -13.95M | -14.23M | -16.45M |
EBIT | -11.19M | -14.01M | -17.4M | -22.9M | -24.08M | -19.38M | -18.8M | -16.29M | -17.63M | -22.57M | -22.9M | -18.86M | -17.27M | -15.87M | -14.81M | -14.85M | -15.12M | -17.35M |
Depreciation & Amortization | 424K | 580K | 599K | 609K | 651K | 646K | 692K | 742K | 772K | 868K | 890K | 917K | 935K | 901K | 903K | 899K | 888K | 900K |